Study group | Parameter | Distribution | Reference |
Foreign-born, HIV-seronegative, aged ≥5 years | LTBI prevalence | beta(1,1) | Assumption |
TST sensitivity | beta(143,37) | See online supplementary table S2 | |
TST specificity | beta(7,3) | Assumption | |
QFT-IT sensitivity | beta(80,29) | See online supplementary table S2 | |
QFT-IT specificity | beta(9,1) | Assumption | |
TSPOT sensitivity | beta(36,20) | See online supplementary table S2 | |
TSPOT specificity | beta(9,1) | Assumption | |
Foreign-born, HIV-seronegative, aged <5 years | LTBI prevalence | beta(1,1) | Assumption |
TST sensitivity | beta(90,41) | See online supplementary table S2 | |
TST specificity | beta(7,3) | Assumption | |
QFT-IT sensitivity | beta(54,22) | See online supplementary table S2 | |
QFT-IT specificity | beta(9,1) | Assumption | |
TSPOT sensitivity | beta(56,31) | See online supplementary table S2 | |
TSPOT specificity | beta(9,1) | Assumption | |
Foreign-born, HIV-seropositive, aged ≥5 years | LTBI prevalence | beta(1,1) | Assumption |
TST sensitivity | beta(40,56) | See online supplementary table S2 | |
TST specificity | beta(7,3) | Assumption | |
QFT-IT sensitivity | beta(6,5) | See online supplementary table S2 | |
QFT-IT specificity | beta(9,1) | Assumption | |
TSPOT sensitivity | beta(10,9) | See online supplementary table S2 | |
TSPOT specificity | beta(9,1) | Assumption | |
US-born, HIV-seronegative, aged ≥5 years | LTBI prevalence | beta(1,1) | Assumption |
TST sensitivity | beta(143,37) | See online supplementary table S2 | |
TST specificity | beta(7,3) | Assumption | |
QFT-IT sensitivity | beta(80,29) | See online supplementary table S2 | |
QFT-IT specificity | beta(9,1) | Assumption | |
TSPOT sensitivity | beta(36,20) | See online supplementary table S2 | |
TSPOT specificity | beta(9,1) | Assumption | |
US-born, HIV-seropositive, aged ≥5 years | LTBI prevalence | beta(1,1) | Assumption |
TST sensitivity | beta(40,56) | See online supplementary table S2 | |
TST specificity | beta(7,3) | Assumption | |
QFT-IT sensitivity | beta(6,5) | See online supplementary table S2 | |
QFT-IT specificity | beta(9,1) | Assumption | |
TSPOT sensitivity | beta(10,9) | See online supplementary table S2 | |
TSPOT specificity | beta(9,1) | Assumption |
LTBI, latent TB infection; QFT-IT, QuantiFERON Gold In-Tube; TSPOT, T-SPOT.TB; TST, tuberculin skin test.